• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过卤代烷作用对糖肽类抗生素埃瑞霉素进行修饰及对所得化合物抗菌活性的研究。

Modification of glycopeptide antibiotic eremomycin by the action of alkyl halides and study on antibacterial activity of the compounds obtained.

作者信息

Pavlov A Y, Olsufyeva E N, Berdnikova T F, Malkova I V, Preobrazhenskaya M N, Risbridger G D

机构信息

Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow.

出版信息

J Antibiot (Tokyo). 1994 Feb;47(2):225-32. doi: 10.7164/antibiotics.47.225.

DOI:10.7164/antibiotics.47.225
PMID:8150719
Abstract

Alkylation of glycopeptide antibiotic eremomycin by the action of different alkyl halides leads, depending on the structure of alkyl halides used, to eremomycin derivatives of six types; alkylated at the N-terminus, quaternary compounds at the N-terminus, eremomycin esters, esters of eremocycin alkylated at the N-terminus, esters of eremomycin quaternised at the N-terminus, esters of eremomycin alkylated both at the N-terminus and at the aminogroup of disaccharide branch. Five compounds demonstrated high antibacterial activity in vitro, N-allyleremomycin and methyl ester of N,N-dimethyleremomycin being at least as good as the parent eremomycin.

摘要

在不同卤代烷的作用下,糖肽抗生素埃瑞霉素发生烷基化反应,根据所用卤代烷的结构,会生成六种类型的埃瑞霉素衍生物:N-端烷基化产物、N-端季铵化合物、埃瑞霉素酯、N-端烷基化的埃瑞霉素酯、N-端季铵化的埃瑞霉素酯、N-端和二糖支链氨基均烷基化的埃瑞霉素酯。五种化合物在体外表现出高抗菌活性,N-烯丙基埃瑞霉素和N,N-二甲基埃瑞霉素甲酯的抗菌活性至少与母体埃瑞霉素相当。

相似文献

1
Modification of glycopeptide antibiotic eremomycin by the action of alkyl halides and study on antibacterial activity of the compounds obtained.通过卤代烷作用对糖肽类抗生素埃瑞霉素进行修饰及对所得化合物抗菌活性的研究。
J Antibiot (Tokyo). 1994 Feb;47(2):225-32. doi: 10.7164/antibiotics.47.225.
2
Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal.在N端进行亚硝化、酰化或氨甲酰化修饰的糖肽类抗生素埃瑞霉素和万古霉素衍生物的合成及生物活性
J Antibiot (Tokyo). 1993 Nov;46(11):1731-9. doi: 10.7164/antibiotics.46.1731.
3
A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity.糖肽类抗生素的一种新型化学修饰:埃瑞霉素的氨甲基化衍生物及其抗菌活性。
J Antibiot (Tokyo). 1997 Jun;50(6):509-13. doi: 10.7164/antibiotics.50.509.
4
Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.糖肽类抗生素埃瑞霉素及其去(N-甲基-D-亮氨酰)埃瑞霉素的疏水衍生物对糖肽敏感菌和耐药菌的合成及作用模式
J Med Chem. 2002 Mar 14;45(6):1340-7. doi: 10.1021/jm010460i.
5
Carboxamides and hydrazide of glycopeptide antibiotic eremomycin. Synthesis and antibacterial activity.糖肽类抗生素埃瑞霉素的羧酰胺和酰肼。合成与抗菌活性。
J Antibiot (Tokyo). 1996 Feb;49(2):194-8. doi: 10.7164/antibiotics.49.194.
6
Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.糖肽骨架在糖肽类抗生素疏水衍生物抗菌活性中的作用。
J Med Chem. 2003 Mar 27;46(7):1204-9. doi: 10.1021/jm020320o.
7
[Study of dimerization of polysynthetic derivatives of the antibiotic eremomycin by ESI MS and its role in elucidating antibacterial activity].[通过电喷雾质谱法研究抗生素埃瑞莫霉素多合成衍生物的二聚作用及其在阐明抗菌活性中的作用]
Bioorg Khim. 2000 Aug;26(8):631-40.
8
A modification of the N-terminal amino acid in the eremomycin aglycone.埃瑞莫霉素苷元中N端氨基酸的修饰。
J Antibiot (Tokyo). 1996 Nov;49(11):1157-61. doi: 10.7164/antibiotics.49.1157.
9
[The structure and antimicrobial activity of the partial degradation products of the antibiotic eremomycin].[抗生素埃瑞莫霉素部分降解产物的结构与抗菌活性]
Antibiot Khimioter. 1991 Jun;36(6):28-31.
10
Structure-activity relationships in the series of eremomycin carboxamides.埃瑞莫霉素羧酰胺系列中的构效关系。
J Antibiot (Tokyo). 2000 Mar;53(3):286-93. doi: 10.7164/antibiotics.53.286.

引用本文的文献

1
N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.替考拉宁抗生素的 N-端胍基衍生物对耐糖肽肠球菌粪肠球菌具有很强的活性。
J Antibiot (Tokyo). 2020 Sep;73(9):603-614. doi: 10.1038/s41429-020-0313-6. Epub 2020 May 15.
2
Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics.一系列半合成多环糖肽抗生素的构效关系
Russ J Bioorg Chem. 2006;32(4):303-322. doi: 10.1134/S1068162006040017.
3
N-Terminus Alkylation of Vancomycin: Ligand Binding Affinity, Antimicrobial Activity, and Site-Specific Nature of Quaternary Trimethylammonium Salt Modification.
万古霉素的N端烷基化:配体结合亲和力、抗菌活性及季铵盐修饰的位点特异性本质
ACS Infect Dis. 2018 Oct 12;4(10):1468-1474. doi: 10.1021/acsinfecdis.8b00152. Epub 2018 Aug 8.
4
The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.抗病毒药物研发的下十个故事(E 部分):新进展、新进展和新冒险。
Med Res Rev. 2011 Jan;31(1):118-60. doi: 10.1002/med.20179.
5
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.糖肽类抗生素半合成衍生物对猫(猫传染性腹膜炎病毒)和人(严重急性呼吸综合征)冠状病毒的抑制作用
Antiviral Res. 2006 Oct;72(1):20-33. doi: 10.1016/j.antiviral.2006.03.005. Epub 2006 Apr 6.